Furthermore, this indicates that CREB may not only be targeted for amelioration of cognitive deficits seen in normal aging, it could also be an important pharmacological target in the prevention or treatment of Alzheimer’s disease. The gene discussed is CREB1; the disease is early-onset autosomal dominant Alzheimer disease.